Matthew Simon Slater, MD | |
2500 Ne Neff Rd, Bend, OR 97701-6015 | |
(541) 388-4333 | |
(541) 388-3446 |
Full Name | Matthew Simon Slater |
---|---|
Gender | Male |
Speciality | Thoracic Surgery |
Experience | 31 Years |
Location | 2500 Ne Neff Rd, Bend, Oregon |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1487662912 | NPI | - | NPPES |
150101 | Medicaid | OR |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | MD18895 (Oregon) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Charles Medical Center - Bend | Bend, OR | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
St Charles Health System Inc | 8729111513 | 206 |
News Archive
A new transparent, bioinspired coating makes ordinary glass tough, self-cleaning and incredibly slippery, a team from the Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard School of Engineering and Applied Sciences (SEAS) reported online in the July 31 edition of Nature Communications.
U.S. price increases on popular branded drugs in the past year have been more than six times the overall rate of inflation for consumer goods, while spending on specialty medications is up nearly 23 percent, according to data compiled by Express Scripts for its first quarterly drug trend report.
News outlets report on the cost of and questions surrounding Angelina Jolie's decision to have genetic testing and then to undergo a double mastectomy as preventive surgery.
Technology developed at The University of Nottingham has been used in a breakthrough study aimed at developing the first comprehensive model of a fully functioning fetal heart.
Benitec Biopharma, a biopharmaceutical company focused on providing potentially curative therapies with its proprietary gene-silencing technology called ddRNAi or "expressed RNAi," is pleased to advise that the fifth patient in the company's 'first in man', Phase I/IIa dose escalation clinical trial of TT-034 for hepatitis C virus (HCV) infection, has today, been dosed at the Duke Clinical Research Unit.
› Verified 2 days ago
Entity Name | St Charles Health System Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023331303 PECOS PAC ID: 8729111513 Enrollment ID: O20100730000227 |
News Archive
A new transparent, bioinspired coating makes ordinary glass tough, self-cleaning and incredibly slippery, a team from the Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard School of Engineering and Applied Sciences (SEAS) reported online in the July 31 edition of Nature Communications.
U.S. price increases on popular branded drugs in the past year have been more than six times the overall rate of inflation for consumer goods, while spending on specialty medications is up nearly 23 percent, according to data compiled by Express Scripts for its first quarterly drug trend report.
News outlets report on the cost of and questions surrounding Angelina Jolie's decision to have genetic testing and then to undergo a double mastectomy as preventive surgery.
Technology developed at The University of Nottingham has been used in a breakthrough study aimed at developing the first comprehensive model of a fully functioning fetal heart.
Benitec Biopharma, a biopharmaceutical company focused on providing potentially curative therapies with its proprietary gene-silencing technology called ddRNAi or "expressed RNAi," is pleased to advise that the fifth patient in the company's 'first in man', Phase I/IIa dose escalation clinical trial of TT-034 for hepatitis C virus (HCV) infection, has today, been dosed at the Duke Clinical Research Unit.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Matthew Simon Slater, MD 2500 Ne Neff Road, St. Charles Medical Center, Bend, OR 97701-6353 Ph: (541) 382-4321 | Matthew Simon Slater, MD 2500 Ne Neff Rd, Bend, OR 97701-6015 Ph: (541) 388-4333 |
News Archive
A new transparent, bioinspired coating makes ordinary glass tough, self-cleaning and incredibly slippery, a team from the Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard School of Engineering and Applied Sciences (SEAS) reported online in the July 31 edition of Nature Communications.
U.S. price increases on popular branded drugs in the past year have been more than six times the overall rate of inflation for consumer goods, while spending on specialty medications is up nearly 23 percent, according to data compiled by Express Scripts for its first quarterly drug trend report.
News outlets report on the cost of and questions surrounding Angelina Jolie's decision to have genetic testing and then to undergo a double mastectomy as preventive surgery.
Technology developed at The University of Nottingham has been used in a breakthrough study aimed at developing the first comprehensive model of a fully functioning fetal heart.
Benitec Biopharma, a biopharmaceutical company focused on providing potentially curative therapies with its proprietary gene-silencing technology called ddRNAi or "expressed RNAi," is pleased to advise that the fifth patient in the company's 'first in man', Phase I/IIa dose escalation clinical trial of TT-034 for hepatitis C virus (HCV) infection, has today, been dosed at the Duke Clinical Research Unit.
› Verified 2 days ago
Angelo A Vlessis, MD, PHD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 2500 Ne Neff Rd, Bend, OR 97701 Phone: 541-388-1636 Fax: 541-388-1719 |